Australia\u2019s Pharmaceutical Benefits Scheme (PBS) is supposed to make essential medicines affordable for everyone. However, many everyday medications, including painkillers, hormone replacement therapy (HRT), and incontinence treatments, are not subsidized under the PBS. As a result, patients are faced with out-of-pocket expenses that can add up quickly, especially for those with chronic conditions or on fixed incomes.<\/p>\n\n\n\n
Imagine dealing with a long-term health issue, such as incontinence, and knowing that essential medication to help manage your condition is not covered by the PBS. For those affected, this is their reality. While certain medications like oxybutynin are subsidized under the PBS, they often come with side effects that make them unsuitable for many patients, especially older Australians. So, patients often turn to alternatives, but with this comes a high price tag. Some incontinence medications can cost up to $80 a month, which quickly adds up to nearly $1,000 a year.<\/p>\n\n\n\n
But it\u2019s not just incontinence treatments. Many HRT therapies and pain relief drugs are also excluded from the PBS, leaving Australians without financial relief for what are often lifelong conditions. The cost of these medicines can range from $20 to $100, but given how frequently they need to be used, these costs add up, placing a significant strain on people\u2019s finances, explains ABC News<\/a>. The pensioners, those on low incomes, and those living with chronic health conditions are disproportionately affected by these gaps in PBS coverage.<\/p>\n\n\n\n